42 - Aspergillosis: What Is the Best Agent for Treatment in 2025?

Monday, October 20, 2025

8:30 AM - 9:00 AM US ET

Location: B206

Speaker(s)

Paschalis Vergidis, MD, MS, FIDSA (he/him/his)

Associate Professor of Medicine, Director of Hematology/Oncology Infectious Diseases
Mayo Clinic
Rochester, MN, United States

Slides

Disclosure(s):

Paschalis Vergidis, MD, MS, FIDSA: Ansun Biopharma: Grant/Research Support; F2G Limited: Grant/Research Support; Merck and Co: Honoraria; Mundipharma: Grant/Research Support; Scynexis Inc.: Advisor/Consultant, Grant/Research Support; Zepto Life Technology: Grant/Research Support